Structures by: El-Emam A. A.
Total: 71
C13H11N3OS
C13H11N3OS
RSC Advances (2020) 10, 60 36806-36817
a=4.6908(2)Å b=9.2376(3)Å c=14.6613(3)Å
α=94.308(2)° β=93.766(2)° γ=100.924(3)°
C11H9N3OS2
C11H9N3OS2
RSC Advances (2020) 10, 60 36806-36817
a=14.5546(2)Å b=4.9907(5)Å c=17.1813(3)Å
α=90° β=113.268(2)° γ=90°
C14H21N3S
C14H21N3S
RSC Advances (2020) 10, 17 9840-9853
a=9.8339(2)Å b=15.8974(2)Å c=9.4749(2)Å
α=90° β=114.464(2)° γ=90°
C18H20FN3S
C18H20FN3S
RSC Advances (2020) 10, 17 9840-9853
a=6.7254(7)Å b=10.9787(5)Å c=11.9955(10)Å
α=116.607(6)° β=94.587(8)° γ=90.941(6)°
C18H20BrN3S
C18H20BrN3S
RSC Advances (2020) 10, 17 9840-9853
a=6.7648(2)Å b=11.4551(2)Å c=11.4985(2)Å
α=110.417(2)° β=95.240(2)° γ=93.613(2)°
3-(Adamantan-1-yl)-4-(2-bromo-4-fluorophenyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C18H19BrFN3S
Acta Crystallographica Section E (2020) 76, 2 162-166
a=6.84730(10)Å b=12.5587(2)Å c=19.8090(3)Å
α=90° β=90° γ=90°
3-(Adamantan-1-yl)-4-(4-chlorophenyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C18H20ClN3S
Acta Crystallographica Section E (2015) 71, 2 o115-o116
a=23.1302(5)Å b=23.1302(5)Å c=6.4100(2)Å
α=90° β=90° γ=90°
3-[(4-Benzylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazole-2-thione
C18H20N4OS2
Acta Crystallographica Section E (2015) 71, 3 o175-o176
a=10.6909(5)Å b=29.3658(13)Å c=15.6179(6)Å
α=90° β=130.283(2)° γ=90°
2-(Adamantan-1-yl)-5-(4-fluorophenyl)-1,3,4-oxadiazole
C18H19FN2O
Acta Crystallographica Section E (2019) 75, 5 611-615
a=18.2525(4)Å b=7.07855(16)Å c=11.2207(2)Å
α=90° β=98.556(2)° γ=90°
2-(Adamantan-1-yl)-5-(4-chlorophenyl)-1,3,4-oxadiazole
C18H19ClN2O
Acta Crystallographica Section E (2019) 75, 5 611-615
a=13.08241(19)Å b=6.49259(9)Å c=18.5129(3)Å
α=90° β=105.5609(16)° γ=90°
6-Chloro-5-isopropylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C7H9ClN2O2
Acta Crystallographica Section E (2014) 70, 11 o1144-o1145
a=11.2244(4)Å b=6.8288(3)Å c=11.6641(5)Å
α=90.00° β=104.577(2)° γ=90.00°
3-(Adamantan-1-yl)-4-(4-fluorophenyl)-1-[(4-phenylpiperazin-1-yl)methyl]-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C29H34FN5S
Acta Crystallographica Section E (2017) 73, 8 1135-1139
a=10.4173(5)Å b=10.9849(5)Å c=12.0002(6)Å
α=72.769(2)° β=84.623(2)° γ=89.244(2)°
3-(Adamantan-1-yl)-4-(4-fluorophenyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C30H36FN5OS
Acta Crystallographica Section E (2017) 73, 8 1135-1139
a=11.3074(7)Å b=12.1576(8)Å c=20.4976(13)Å
α=90° β=101.328(2)° γ=90°
4-Phenylpiperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide
C10H15N2,C7H8ClN2O2
Acta Crystallographica Section E (2015) 71, 8 956-959
a=20.5012(3)Å b=7.45650(10)Å c=23.1414(3)Å
α=90° β=90.6390(10)° γ=90°
4-Phenylpiperazin-1-ium 6-chloro-5-ethyl-2,4-dioxopyrimidin-1-ide
C10H15N2,C6H6ClN2O2
Acta Crystallographica Section E (2015) 71, 8 956-959
a=21.6760(10)Å b=7.6446(5)Å c=20.5444(8)Å
α=90° β=95.065(5)° γ=90°
2-(Adamantan-1-yl)-5-(4-bromophenyl)-1,3,4-oxadiazole
C18H19BrN2O
Acta Crystallographica Section E (2014) 70, 12 o1231-o1232
a=13.2571(5)Å b=6.4753(3)Å c=19.6761(7)Å
α=90.00° β=114.924(2)° γ=90.00°
3-{[4-(2-Methoxyphenyl)piperazin-1-yl]methyl}-5-(thiophen-2-yl)-1,3,4-oxadiazole-2(3<i>H</i>)-thione
C18H20N4O2S2
Acta Crystallographica Section E (2016) 72, 2 269-272
a=15.2925(2)Å b=10.07450(10)Å c=11.97260(10)Å
α=90° β=93.4130(10)° γ=90°
3-(1-Adamantyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C25H35N5OS
Acta Crystallographica Section E (2010) 66, 7 o1756
a=11.0203(2)Å b=12.1148(2)Å c=18.7624(4)Å
α=90.00° β=103.4730(10)° γ=90.00°
<i>N</i>'-[(2-<i>n</i>-Butyl-4-chloro-1<i>H</i>-imidazol-5- yl)methylidene]adamantane-1-carbohydrazide sesquihydrate ethanol hemisolvate
C19H27ClN4O,0.5C2H6O,1.5H2O
Acta Crystallographica Section E (2010) 66, 8 o2131
a=7.9867(6)Å b=16.8478(13)Å c=16.9656(13)Å
α=97.3410(10)° β=100.3760(10)° γ=97.5050(10)°
2-Benzylsulfanyl-4-pentyl-6-(phenylsulfanyl)pyrimidine-5-carbonitrile
C23H23N3S2
Acta Crystallographica Section E (2011) 67, 11 o3126
a=9.00930(10)Å b=8.21370(10)Å c=28.6398(3)Å
α=90.00° β=98.4270(10)° γ=90.00°
<i>N</i>'-(Adamantan-2-ylidene)thiophene-2-carbohydrazide
C15H18N2OS
Acta Crystallographica Section E (2011) 67, 11 o3127
a=16.7262(2)Å b=12.56630(10)Å c=13.5562(2)Å
α=90.00° β=102.4730(10)° γ=90.00°
2-Ethoxymethyl-6-ethyl-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione
C8H13N3O3
Acta Crystallographica Section E (2012) 68, 2 o346
a=20.4078(19)Å b=4.4343(3)Å c=22.6285(17)Å
α=90.00° β=111.813(10)° γ=90.00°
2-{[(2-Methylprop-2-en-1-yl)oxy]methyl}-6-phenyl-2,3,4,5-tetrahydro-1,2,4- triazine-3,5-dione
C14H15N3O3
Acta Crystallographica Section E (2012) 68, 2 o347
a=4.6162(5)Å b=11.7896(14)Å c=12.5769(10)Å
α=81.588(8)° β=85.836(7)° γ=87.245(9)°
1-[(Cyclopropylmethoxy)methyl]-6-(3,4-dimethoxybenzyl)-5-ethyl-1,2,3,4- tetrahydropyrimidine-2,4-dione ethanol hemisolvate
C20H26N2O5,0.5(C2H6O)
Acta Crystallographica Section E (2012) 68, 2 o349-o350
a=14.0251(5)Å b=9.4285(3)Å c=30.8606(12)Å
α=90.00° β=91.580(3)° γ=90.00°
6-(3,5-Dimethylbenzyyl)-5-ethyl-1-[(3-phenylpropoxy)methyl]-1,2,3,4- tetrahydropyrimidine-2,4-dione
C25H30N2O3
Acta Crystallographica Section E (2012) 68, 2 o316
a=4.8276(4)Å b=14.9398(10)Å c=15.4574(12)Å
α=76.949(6)° β=89.296(6)° γ=88.267(6)°
<i>N</i>'-[(1<i>E</i>)-(2,6-Difluorophenyl)methylidene]thiophene- 2-carbohydrazide
C12H8F2N2OS
Acta Crystallographica Section E (2012) 68, 2 o315
a=6.5032(3)Å b=7.7516(4)Å c=11.5224(5)Å
α=95.184(4)° β=103.344(4)° γ=94.285(4)°
<i>N</i>'-[(1<i>E</i>)-(4-Fluorophenyl)methylidene]thiophene-2-carbohydrazide
C12H9FN2OS
Acta Crystallographica Section E (2012) 68, 2 o314
a=13.3076(11)Å b=5.6015(4)Å c=15.3062(12)Å
α=90.00° β=104.166(9)° γ=90.00°
Ethyl 4-{[3-(adamantan-1-yl)-4-phenyl-5-sulfanylidene-4,5-dihydro-1<i>H</i>- 1,2,4-triazol-1-yl]methyl}piperazine-1-carboxylate
C26H35N5O2S
Acta Crystallographica Section E (2012) 68, 2 o531
a=12.0469(6)Å b=20.9213(10)Å c=10.3249(5)Å
α=90.00° β=109.851(6)° γ=90.00°
1-[(Cyclopropylmethoxy)methyl]-5-ethyl-6-(4-methylbenzyl)-1,2,3,4- tetrahydropyrimidine-2,4-dione
C19H24N2O3
Acta Crystallographica Section E (2012) 68, 2 o348
a=15.6080(13)Å b=8.1330(6)Å c=27.496(2)Å
α=90.00° β=93.397(7)° γ=90.00°
6-(3,5-dimethylbenzyl)-5-ethyl-1-(phenoxyethoxymethyl)uracil
C24H28N2O4
Acta Crystallographica Section E (2011) 67, 11 o2839
a=16.1116(6)Å b=4.8211(2)Å c=27.5125(10)Å
α=90.00° β=92.574(3)° γ=90.00°
4-Benzyl-<i>N</i>-methylpiperazine-1-carbothioamide
C13H19N3S
Acta Crystallographica Section E (2012) 68, 3 o712-o713
a=5.84720(10)Å b=80.3936(9)Å c=8.62190(10)Å
α=90.00° β=103.2920(10)° γ=90.00°
1-{[(2,3-Dihydro-1<i>H</i>-inden-2-yl)oxy]methyl}quinazoline- 2,4(1<i>H</i>,3<i>H</i>)-dione
C18H16N2O3
Acta Crystallographica Section E (2012) 68, 6 o1866-o1867
a=7.6684(8)Å b=10.0717(10)Å c=10.6748(11)Å
α=87.199(8)° β=78.332(8)° γ=70.569(8)°
5-Methoxy-2-[(5-methoxy-1<i>H</i>-indol-1-yl)carbonyl]-1<i>H</i>-indole
C19H16N2O3
Acta Crystallographica Section E (2012) 68, 6 o1775
a=11.3153(4)Å b=12.1183(5)Å c=17.1300(6)Å
α=76.251(3)° β=79.747(3)° γ=88.913(3)°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(<i>E</i>)-(2- hydroxybenzylidene)amino]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C31H38N6OS
Acta Crystallographica Section E (2012) 68, 6 o1766-o1767
a=10.6015(5)Å b=12.0283(7)Å c=22.7865(12)Å
α=90.00° β=101.222(4)° γ=90.00°
2-[(Cyclohex-3-en-1-ylmethoxy)methyl]-6-phenyl-1,2,4-triazine- 3,5(2<i>H</i>,4<i>H</i>)-dione
C17H19N3O3
Acta Crystallographica Section E (2012) 68, 6 o1776-o1777
a=4.7924(6)Å b=13.7083(19)Å c=11.8293(15)Å
α=90.00° β=101.538(12)° γ=90.00°
3-(Adamantan-1-yl)-4-benzyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C19H23N3S
Acta Crystallographica Section E (2014) 70, 7 o766-o767
a=7.6407(4)Å b=10.5150(5)Å c=12.3434(5)Å
α=67.1806(13)° β=72.9688(13)° γ=70.0695(14)°
3-(Adamantan-1-yl)-4-(prop-2-en-1-yl)-1<i>H</i>-1,2,4-triazole- 5(4<i>H</i>)-thione
C15H21N3S
Acta Crystallographica Section E (2012) 68, 3 o656
a=13.5833(17)Å b=8.6483(6)Å c=13.6973(14)Å
α=90.00° β=115.938(14)° γ=90.00°
6-(2-Methylpropyl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5- carbonitrile
C9H11N3OS
Acta Crystallographica Section E (2012) 68, 3 o676-o677
a=25.8985(6)Å b=7.0479(2)Å c=11.1811(2)Å
α=90.00° β=98.527(2)° γ=90.00°
2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole
C18H19N3O3
Acta Crystallographica Section E (2012) 68, 3 o795
a=6.8502(6)Å b=6.5705(7)Å c=17.6761(15)Å
α=90.00° β=98.432(8)° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-ethylpiperazin-1-yl)methyl]-4-[(<i>E</i>)-(4- hydroxybenzylidene)amino]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H36N6OS
Acta Crystallographica Section E (2012) 68, 3 o657-o658
a=16.1006(6)Å b=14.2182(5)Å c=11.4641(4)Å
α=90.00° β=92.440(4)° γ=90.00°
2-[(2-Methoxyethyl)sulfanyl]-4-(2-methylpropyl)-6-oxo-1,6-dihydropyrimidine- 5-carbonitrile
C12H17N3O2S
Acta Crystallographica Section E (2012) 68, 5 o1379
a=5.0379(5)Å b=10.5453(10)Å c=13.3936(13)Å
α=85.274(8)° β=82.170(8)° γ=83.034(8)°
1-(Adamantan-1-yl)-3-(4-fluorophenyl)thiourea
C17H21FN2S
Acta Crystallographica Section E (2012) 68, 5 o1523
a=6.4274(5)Å b=11.4727(9)Å c=11.5870(9)Å
α=113.510(6)° β=94.721(6)° γ=94.837(6)°
5-(Adamantan-1-yl)-3-[(4-benzylpiperazin-1-yl)methyl]-1,3,4-oxadiazole- 2(3<i>H</i>)-thione
C24H32N4O1S1
Acta Crystallographica Section E (2012) 68, 7 o2172-o2173
a=11.6417(9)Å b=17.198(2)Å c=12.7740(10)Å
α=90.00° β=115.060(10)° γ=90.00°
2-[(4-Chlorobenzyl)sulfanyl]-4-(2-methylpropyl)-6-[3- (trifluoromethyl)anilino]pyrimidine-5-carbonitrile
C23H20ClF3N4S
Acta Crystallographica Section E (2012) 68, 7 o2059-o2060
a=15.3906(6)Å b=15.7040(7)Å c=15.9129(7)Å
α=89.568(3)° β=74.825(4)° γ=62.980(4)°
3-(Adamantan-1-yl)-4-[(<i>E</i>)-(2,6-difluorobenzylidene)amino]-1-[(4- phenylpiperazin-1-yl)methyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C30H34F2N6S
Acta Crystallographica Section E (2012) 68, 7 o2031
a=17.2712(3)Å b=7.71410(10)Å c=21.3157(4)Å
α=90.00° β=95.245(2)° γ=90.00°
5-Propyl-6-(<i>p</i>-tolylsulfanyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C14H16N2O2S
Acta Crystallographica Section E (2014) 70, 2 o179-o180
a=11.8356(3)Å b=10.3040(2)Å c=13.3999(3)Å
α=90.00° β=119.850(2)° γ=90.00°
2-[(4-Chlorobenzyl)sulfanyl]-4-(2-methylpropyl)-6-(phenylsulfanyl)pyrimidine- 5-carbonitrile
C22H20ClN3S2
Acta Crystallographica Section E (2012) 68, 7 o2055-o2056
a=13.7771(2)Å b=8.49610(10)Å c=18.5878(2)Å
α=90.00° β=97.5590(10)° γ=90.00°
6-[(2-Methylphenyl)sulfanyl]-5-propylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C14H16N2O2S
Acta Crystallographica Section E (2014) 70, 7 o768-o769
a=10.3434(8)Å b=5.3355(3)Å c=24.4948(18)Å
α=90.00° β=91.171(3)° γ=90.00°
3-(Adamantan-1-yl)-4-ethyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C14H21N3S
Acta Crystallographica Section E (2012) 68, 5 o1347
a=13.8329(7)Å b=7.3107(4)Å c=17.5302(12)Å
α=90.00° β=128.157(4)° γ=90.00°
3-[(<i>N</i>-Methylanilino)methyl]-5-(thiophen-2-yl)-1,3,4-oxadiazole- 2(3<i>H</i>)-thione
C14H13N3OS2
Acta Crystallographica Section E (2012) 68, 5 o1345-o1346
a=11.9682(8)Å b=7.4526(5)Å c=17.0749(14)Å
α=90.00° β=108.072(6)° γ=90.00°
3-(1-Adamantyl)-4-amino-1-(2-benzoyl-1-phenylethyl)-1<i>H</i>-1,2,4-triazol- 5(4<i>H</i>)-thione
C27H30N4OS
Acta Crystallographica Section E (2012) 68, 5 o1439-o1440
a=11.9409(3)Å b=9.5478(3)Å c=22.0034(6)Å
α=90.00° β=103.610(2)° γ=90.00°
2-{[5-(Adamantan-1-yl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]sulfanyl}- <i>N</i>,<i>N</i>-dimethylethanamine
C17H28N4S
Acta Crystallographica Section E (2012) 68, 5 o1356
a=12.5133(7)Å b=10.3779(5)Å c=14.3044(8)Å
α=90.00° β=106.766(3)° γ=90.00°
6-Methyl-1-({[(2<i>E</i>)-2-methyl-3-phenylprop-2-en-1-yl]oxy}methyl)- 1,2,3,4-tetrahydroquinazoline-2,4-dione
C20H20N2O3
Acta Crystallographica Section E (2012) 68, 6 o1768-o1769
a=16.2352(8)Å b=13.6934(6)Å c=7.8900(4)Å
α=90.00° β=102.606(5)° γ=90.00°
6-Chloro-1-({[(2<i>E</i>)-2-methyl-3-phenylprop-2-en-1-yl]oxy}methyl)- 1,2,3,4-tetrahydroquinazoline-2,4-dione
C19H17ClN2O3
Acta Crystallographica Section E (2012) 68, 6 o1770-o1771
a=7.6179(3)Å b=9.8168(4)Å c=11.7009(6)Å
α=73.937(4)° β=83.651(3)° γ=80.942(3)°
3-(Adamantan-1-yl)-4-methyl-1-[(4-phenylpiperazin-1-yl)methyl]-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione dichloromethane hemisolvate
2(C24H33N5S),CH2Cl2
Acta Crystallographica Section E (2012) 68, 6 o1772-o1773
a=66.8490(16)Å b=22.1076(4)Å c=6.51090(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-(Adamantan-2-ylidene)benzohydrazide
C17H20N2O1
Acta Crystallographica Section E (2012) 68, 7 o2247-o2248
a=7.9698(3)Å b=17.5466(8)Å c=20.1350(8)Å
α=90.00° β=90.00° γ=90.00°
2-Benzylsulfanyl-4-[(4-methylphenyl)sulfanyl]-6-pentylpyrimidine-5-carbonitrile
C24H25N3S2
Acta Crystallographica Section E (2012) 68, 7 o2054
a=9.9178(2)Å b=8.2235(2)Å c=28.4388(8)Å
α=90.00° β=96.115(2)° γ=90.00°
5-(Adamantan-1-yl)-3-[(2-methoxyethyl)sulfanyl]-4-phenyl-4<i>H</i>-1,2,4-triazole
C21H27N3OS
Acta Crystallographica Section E (2012) 68, 8 o2326
a=22.5107(5)Å b=9.7642(2)Å c=19.5594(3)Å
α=90.00° β=116.6790(10)° γ=90.00°
5-(Adamantan-1-yl)-3-(benzylsulfanyl)-4-methyl-4<i>H</i>-1,2,4-triazole
C20H25N3S
Acta Crystallographica Section E (2012) 68, 8 o2427-o2428
a=6.4554(3)Å b=14.0258(6)Å c=20.2264(9)Å
α=94.610(2)° β=95.568(3)° γ=98.317(3)°
3-(Adamantan-1-yl)-4-ethyl-1-[(4-phenylpiperazin-1-yl)methyl]-1<i>H</i>-1,2,4- triazole-5(4<i>H</i>)-thione
C25H35N5S1
Acta Crystallographica Section E (2012) 68, 8 o2380-o2381
a=27.382(4)Å b=6.5083(7)Å c=13.369(2)Å
α=90.00° β=90.00° γ=90.00°
3-(Adamantan-1-yl)-4-ethyl-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H37N5OS
Acta Crystallographica Section E (2014) 70, 1 o25-o26
a=19.8170(3)Å b=11.9384(3)Å c=21.7807(4)Å
α=90.00° β=107.886(2)° γ=90.00°
3-[(4-Phenylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazole-2-thione
C17H18N4OS2
Acta Crystallographica Section E (2013) 69, 5 o684
a=26.1721(17)Å b=5.7253(3)Å c=23.7008(18)Å
α=90.00° β=97.802(6)° γ=90.00°
3-(Adamantan-1-yl)-4-[(<i>E</i>)-(2,6-difluorobenzylidene)amino]-1-[(4-ethylpiperazin-1-yl)methyl]-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C26H34F2N6S
Acta Crystallographica Section E (2013) 69, 5 o685-o686
a=17.0824(11)Å b=7.8212(6)Å c=19.6691(14)Å
α=90.00° β=92.249(6)° γ=90.00°
5-(Adamantan-1-yl)-3-anilinomethyl-2,3-dihydro-1,3,4-oxadiazole-2-thione
C19H23N3OS
Acta Crystallographica Section E (2013) 69, 5 o729
a=14.1326(13)Å b=7.1179(5)Å c=18.3685(16)Å
α=90.00° β=105.546(10)° γ=90.00°
5-(Adamantan-1-yl)-3-[(4-fluoroanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione
C19H22FN3OS
Acta Crystallographica Section E (2013) 69, 5 o730
a=7.1683(8)Å b=10.6621(11)Å c=23.592(3)Å
α=90.00° β=90.00° γ=90.00°
5-(Adamantan-1-yl)-<i>N</i>-methyl-1,3,4-thiadiazol-2-amine
C13H19N3S
Acta Crystallographica Section E (2013) 69, 5 o683
a=10.4394(12)Å b=13.0910(13)Å c=10.8871(15)Å
α=90.00° β=118.008(16)° γ=90.00°
4-Benzyl-3-(thiophen-2-yl)-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C13H11N3S2
Acta Crystallographica Section E (2013) 69, 5 o697
a=13.422(2)Å b=6.1670(7)Å c=16.596(2)Å
α=90.00° β=111.972(15)° γ=90.00°
3-(Adamantan-1-yl)-4-methyl-1-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C25H32F3N5S
Acta Crystallographica Section E (2013) 69, 5 o695-o696
a=28.8100(15)Å b=6.6052(4)Å c=25.7717(14)Å
α=90.00° β=90.00° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-ethyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H37N5S
Acta Crystallographica Section E (2013) 69, 12 o1813-o1814
a=10.5618(2)Å b=11.2123(2)Å c=11.3084(2)Å
α=89.9740(10)° β=77.6190(10)° γ=70.8420(10)°
<i>N</i>-(Adamantan-1-yl)-1,2,3,4-tetrahydroisoquinoline-2-carbothioamide
C20H26N2S
Acta Crystallographica Section E (2013) 69, 12 o1815
a=19.1707(5)Å b=6.4106(2)Å c=14.2838(3)Å
α=90.00° β=103.366(2)° γ=90.00°
4-(2-Methoxyphenyl)piperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide
C11H17N2O,C7H8ClN2O2
Acta Crystallographica Section E (2014) 70, 3 o245-o246
a=8.9416(2)Å b=10.5152(3)Å c=20.5626(5)Å
α=90.00° β=98.8320(10)° γ=90.00°